You are here: Industry Insights > Novavax

News List

S Korea authorises use of Novavax COVID-19 vaccine ExpressPharma
January 13, 2022
South Korean vaccine developer SK Bioscience said it will produce the Novavax vaccine
Ardena Expands Capacity to Satisfy Novavax COVID Vaccine Demand contractpharma
January 13, 2022
Site in Södertälje, Sweden will see capacity increases in purification and fractionation of GMP manufacturing.
South Korea Approves Novavax COVID-19 Vaccine contractpharma
January 12, 2022
Nuvaxovid is the first protein-based COVID-19 vaccine granted approval in South Korea.
Novavax, SII File COVID Vax EUA in South Africa contractpharma
January 10, 2022
If authorized, the vaccine will be manufactured by and commercialized by SII in South Africa under the brand name Covovax.
AstraZeneca and Novavax say their vaccines are effective against Omicron pharmatimes
January 05, 2022
WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.
Novavax submits final data to US FDA as prerequisite to EUA application request for COVID-19 vaccine ExpressPharma
January 04, 2022
Novavax, Inc recently announced that it has completed submission of the final data package, including the complete chemistry, manufacturing and controls module...
Novavax files Covid-19 vaccine data with FDA ahead of EUA application Pharmaceutical-Technology
January 04, 2022
Novavax has submitted the final data package with the US Food and Drug Administration (FDA) to satisfy the requirements for seeking emergency use authorization (EUA) for its Covid-19 vaccine with Matrix-M adjuvant, NVX-CoV2373.
DCGI grants EUA to Novavax’s Covid-19 vaccine Pharmaceutical-Technology
December 29, 2021
The Drugs Controller General of India (DCGI) has granted emergency use authorization (EUA) to Novavax’s Covid-19 vaccine, NVX-CoV2373, with Matrix-M adjuvant to prevent Covid-19 in adults aged 18 years and older.
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India prnasia
December 29, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute...
Novavax Covid vaccine could win Dutch approval Friday as mRNA alternative FirstWordPharma
December 27, 2021
The Dutch Health Council recommended that adults who are unvaccinated against COVID-19, and object to using vaccines based on newer mRNA techniques...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page